From: Genetic variants in migraine: a field synopsis and systematic re-analysis of meta-analyses
Author, year | Gene/variant | Comparison | OR (95%CI) | P-value | Subtypes | No. of cases/controls | FPRP Values at Prior probability | BFDP 0.05 | BFDP 0.001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR 1.2 | OR 1.5 | |||||||||||
0.05 | 0.001 | 0.05 | 0.001 | |||||||||
Liu L, 2019 [48] | MTHFR/rs1801133 | T vs. C | 1.28 (1.09–1.51) | 0.003 | MA | 4313/28092 | 0.226 | 0.939 | 0.063 | 0.778 | 0.560 | 0.985 |
Liu L, 2019 [48] | MTHFR/rs1801133 | CT + TT vs. CC | 1.20 (1.00–1.44) | 0.049 | MA | 4313/28092 | 0.655 | 0.990 | 0.489 | 0.981 | 0.904 | 0.998 |
Liu L, 2019 [48] | MTHFR/rs1801133 | TT vs. CT + CC | 1.46 (1.10–1.95) | 0.010 | MA | 4313/28092 | 0.682 | 0.991 | 0.256 | 0.948 | 0.788 | 0.995 |
Liu L, 2019 [48] | MTHFR/rs1801133 | TT vs. CC | 1.51 (1.09–2.08) | 0.012 | MA | 4313/28092 | 0.735 | 0.993 | 0.314 | 0.960 | 0.812 | 0.996 |
Terrazzino S, 2017 [44] | BDNF/rs6265 | GA + AA vs. GG | 1.22 (1.00–1.47) | 0.047 | MA | 717/1593 | 0.617 | 0.988 | 0.413 | 0.974 | 0.882 | 0.997 |
Li L, 2015 [37] | ESR1/rs1801132 | GG vs. CC | 1.59 (1.17–2.15) | 0.003 | MA | 1427/1919 | 0.593 | 0.987 | 0.123 | 0.880 | 0.632 | 0.989 |
Li L, 2015 [37] | ESR1/rs1801132 | GG vs. CG + CC | 1.58 (1.18–2.13) | 0.002 | MA | 1427/1919 | 0.590 | 0.987 | 0.122 | 0.880 | 0.633 | 0.989 |
Chen M, 2015 [35] | TNF-α/rs1800629 | AA+GA vs. GG | 1.17 (1.05–1.30) | 0.004 | MA | 1763/21837 | 0.089 | 0.837 | 0.062 | 0.777 | 0.582 | 0.987 |
Chen M, 2015 [35] | TNF-α/rs1800629 | A vs. G | 1.13 (1.03–1.24) | 0.010 | MA | 1763/21837 | 0.173 | 0.917 | 0.159 | 0.908 | 0.783 | 0.995 |
Chen M, 2015 [35] | TNF-α/rs1800629 | GA vs. GG | 1.17 (1.05–1.31) | 0.005 | MA | 1763/21837 | 0.115 | 0.906 | 0.110 | 0.866 | 0.694 | 0.992 |
Chen M, 2015 [35] | NOS3/rs1799983 | TT vs. GG | 1.61 (1.12–2.31) | 0.010 | MA | 440/881 | 0.770 | 0.994 | 0.345 | 0.965 | 0.816 | 0.996 |
Chen M, 2015 [35] | NOS3/rs1799983 | TT vs. GT + GG | 1.50 (1.08–2.09) | 0.016 | MA | 440/881 | 0.771 | 0.994 | 0.387 | 0.971 | 0.843 | 0.996 |
Liu H, 2011 [23] | 5-HTT/VNTR | 12/other | 1.33 (1.01–1.75) | 0.042 | MA | 176/629 | 0.774 | 0.994 | 0.496 | 0.981 | 0.891 | 0.998 |
Liu H, 2011 [23] | 5-HTT/VNTR | 12/12 vs. 12/other +other | 1.58 (1.07–2.33) | 0.021 | MA | 176/629 | 0.829 | 0.996 | 0.501 | 0.981 | 0.873 | 0.997 |
Schurks M, 2010 [20] | ACE/rs1799752 | II vs. ID + DD | 0.71 (0.55–0.93) | 0.011 | MA | 1761/22310 | 0.667 | 0.991 | 0.266 | 0.950 | 0.801 | 0.995 |
Liu L, 2019 [48] | MTHFR/rs1801131 | C vs. A | 1.43 (1.06–1.92) | 0.018 | MO | 159/1477 | 0.730 | 0.993 | 0.345 | 0.965 | 0.835 | 0.996 |
Liu L, 2019 [48] | MTHFR/rs1801131 | CC vs. AC + AA | 2.74 (1.46–5.14) | 0.002 | MO | 159/1477 | 0.864 | 0.997 | 0.515 | 0.982 | 0.842 | 0.996 |
Liu L, 2019 [48] | MTHFR/rs1801131 | CC vs. AA | 2.83 (1.30–6.16) | 0.009 | MO | 159/1477 | 0.916 | 0.998 | 0.752 | 0.994 | 0.991 | 0.998 |
Liu H, 2011 [23] | 5-HTT/VNTR | 12/other | 1.30 (1.02–1.67) | 0.037 | MO | 319/697 | 0.741 | 0.993 | 0.467 | 0.979 | 0.887 | 0.998 |
Liu H, 2011 [23] | 5-HTT/VNTR | 12/12 vs. 12/other +other | 1.55 (1.11–2.16) | 0.010 | MO | 319/697 | 0.737 | 0.993 | 0.302 | 0.958 | 0.801 | 0.995 |
Schurks M, 2010 [20] | ACE/rs1799752 | II vs. ID + DD | 0.84 (0.70–0.99) | 0.049 | MO | 2853/22310 | 0.570 | 0.986 | 0.417 | 0.974 | 0.888 | 0.998 |